New Jersey substance law

Is Kratom Legal in New Jersey?

Official New Jersey legislative materials reviewed September 6, 2026 described kratom and 7-OH as not presently barred by state law, while multiple pending bills proposed product controls or 7-OH restrictions.

By Paul James Roeser·Reviewed by Stephen LaTourette, Pharm.D., RPh, CADC Intern·Last reviewed September 6, 2026

Published September 6, 2026·Updated September 8, 2026

What is the legal status of kratom in New Jersey?

Official New Jersey legislative materials reviewed on September 6, 2026 described kratom and 7-hydroxymitragynine as not presently barred by state law. That statement is date-specific, the pending proposals could change the rules, and municipal or federal requirements may address separate conduct or products. A bill's introduction, committee vote, or companion designation does not make its proposed restrictions enforceable law.

Legal availability also does not establish identity, purity, dosage, or medical benefit. The national guide to kratom effects, dependence, and withdrawal explains what the plant contains and why concentrated products require separate attention from ordinary leaf material.

Comparison of enforceable New Jersey kratom law with pending legislation that has not taken effect — Current law establishes enforceable requirements; introduced and committee-reported bills describe proposals until enactment and an effective date.

What would New Jersey Assembly Bill A4222 regulate?

A4222 would create consumer-protection rules for product composition, package disclosure, and retail sale; it was introduced on February 19, 2026, not enacted on that date. The introduced text would require label disclosures, restrict dangerous contaminants and synthetic alkaloids, cap 7-OH at 2% of the product's overall alkaloid composition, and prohibit sales to people under 21.

The proposal would also authorize product registration and penalties for specified violations. Those details describe what the bill would do if enacted; they do not establish a current statewide age limit, concentration cap, registration system, or labeling mandate.

Four proposed New Jersey A4222 kratom controls covering labels, product standards, 7-OH concentration, and sales to people under 21 — A4222 proposes four principal consumer protections; none becomes a current requirement unless the bill is enacted.

How would A5359 and S301 change the status of 7-OH?

A5359 and its identical Senate bill, S301, would classify 7-hydroxymitragynine as a Schedule I controlled dangerous substance in New Jersey. The Senate Health, Human Services and Senior Citizens Committee reported S301 favorably on March 16, 2026, but committee approval is one legislative step rather than final enactment.

The distinction matters because concentrated 7-OH products are not equivalent to unaltered kratom leaf. The 7-hydroxymitragynine is a kratom alkaloid sold in concentrated product forms with opioid-receptor activity and dependence risk, without treating a pending state classification as current law.

New Jersey kratom bill tracker distinguishing the purposes of A4222, A5359 and S301, and A1636 — The proposals address different entities: A4222 focuses on kratom product controls, while A5359/S301 and A1636 focus on 7-OH restrictions.

What would New Jersey Assembly Bill A1636 prohibit?

A1636 would classify 7-OH as Schedule I and prohibit the sale, manufacture, and distribution of products made with or containing 7-OH. Its introduced text also describes product recalls, retailer removal deadlines, inventory returns, and penalties. The Legislature labeled that text as introduced pending technical review, so the proposal should not be quoted as an existing product ban.

Does New Jersey legality make kratom safe or medically approved?

No: state legality governs prohibited conduct, product quality governs exposure, and FDA approval governs whether a product is authorized to treat a medical condition. A retail product may vary in alkaloid concentration or contain substances not apparent from its marketing. Kratom and 7-OH are not FDA-approved treatments for pain, anxiety, depression, opioid withdrawal, or opioid use disorder.

When does kratom use require treatment assessment?

Treatment relevance begins when repeated use produces craving, tolerance, withdrawal, impaired control, or disruption at work, school, home, or in relationships. Clinical assessment identifies the substances involved, measures withdrawal and co-occurring symptoms, and determines whether outpatient care or a higher level of support fits the person's needs.

New Jersey residents experiencing those signs can review the scope of kratom addiction treatment. Legal status does not prevent a person from seeking confidential help, and treatment decisions should follow clinical need rather than a product's retail availability.

How should someone verify a New Jersey kratom law change?

Check the official New Jersey Legislature bill page for the latest action, confirm whether the Governor signed a final bill, and read the enacted effective date before relying on a proposed rule. Bill numbers, sponsors, committee actions, amendments, and companion bills can change during a legislative session. A retailer, attorney, or consumer facing a specific legal question should review the current statute and obtain legal advice when necessary.

Four-step New Jersey kratom law verification process using the official bill page, latest action, enactment record, and effective date — Verify a legal change through the official legislative record rather than treating an introduction or committee action as final law.

Frequently asked questions

Is kratom illegal in New Jersey?

Official New Jersey legislative materials reviewed on September 6, 2026 describe kratom and 7-hydroxymitragynine as not presently barred by New Jersey law. Several bills would regulate kratom products or restrict 7-OH, but an introduced or committee-reported bill is not an enacted law.

Does New Jersey have a minimum age for buying kratom?

The proposed New Jersey Kratom Consumer Protection Act, A4222, would prohibit sales to people under 21. The official bill page identified A4222 as introduced and referred to committee, so its proposed age rule should not be represented as current law.

Is 7-OH illegal in New Jersey?

Official committee materials for S301 stated that 7-OH was not presently barred by New Jersey law. A5359/S301 would classify 7-OH as a Schedule I controlled dangerous substance, while A1636 would also ban products containing it. Their status must be checked before relying on that statement.

Does legal status mean kratom is FDA-approved?

No. State legal status and federal medical approval answer different questions. The FDA has not approved kratom or 7-OH to treat pain, opioid withdrawal, anxiety, depression, or another medical condition.

Legal note: This page provides general educational information, not legal advice. The status statement is limited to official materials reviewed on September 6, 2026; verify current statutes and bill histories before acting on it.

Sources & References5Show

New Jersey Legislature, A4222 (2026-2027 session) — Official status page for the proposed New Jersey Kratom Protection Act, introduced February 19, 2026.
New Jersey Legislature, A4222 introduced text — Proposed labeling, product-composition, retailer, and under-21 sales requirements.
New Jersey Legislature, A5359 (2026-2027 session) — Official page identifying A5359 as the Assembly companion to S301 for proposed Schedule I classification of 7-OH.
New Jersey Senate Health Committee statement for S301 — Committee action, proposed Schedule I classification, and dated statement of then-current New Jersey status.
New Jersey Legislature, A1636 introduced text — Proposed Schedule I classification and ban on products containing 7-OH.

Back to New Jersey resources